When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even ...

Eli Lilly started 2024 on a strong note but struggled during the second half of the year. The drugmaker dealt with several ...

Quantum computing has been an up-and-down investment theme over the past few months. The rage kicked off when Alphabet(NASDAQ ...

The capital market reform taskforce is considering tightening regulations for margin loans as it appeared to be a big dragger for the stock market due to misuse and improper regulations, according to ...

Drones are the strategic weapon in modern warfare and we have experienced the use of high-end drone technology in the ...

Our writer lays out some principles a retirement-focused investor could consider when scanning the market for possible shares ...

Stocks have been performing well lately as they seem to have been influenced by the excitement around artificial intelligence ...

Competition is already heating up, with many companies taking a unique approach to developing their quantum computers. One ...

A former dividend enthusiast, Money Talks columnist Darnell Mayberry, reflects on his evolving investment strategy, shifting ...

The S&P 500 index has been one of the best-performers of all time. Launched in 1950s when it was trading at $45.4, the ...

Financial writer recommends buying ARK Genomic Revolution ETF (ARKG) for potential growth in 2025. Explore more here.

According to their analysis, U.S. large value stocks and U.S. small stocks - think the Vanguard Value ETF VTV and Vanguard Small-Cap ETF VB - are likely to give total returns over a decade of between ...